Zobrazeno 1 - 10
of 57
pro vyhledávání: '"COVID-19 Vaccines/adverse effects"'
Publikováno v:
Liječnički vjesnik, Vol 144, Iss 9-10, Pp 322-330 (2022)
Vaccine is the most effective preventive health measure that reduces the risk of developing a severe form of COVID-19 disease. Since it was determined that pregnant women were prone to develop more severe forms of the disease after being pregnant for
Externí odkaz:
https://doaj.org/article/0cd3e7d69a204e9d9ecd6e014f75f725
Autor:
Mario Blekić, Blaženka Kljaić Bukvić
Publikováno v:
Liječnički vjesnik, Vol 143, Iss 5-6, Pp 192-208 (2021)
A global pandemic of coronavirus disease requires a rapid solution by achieving the herd immunity with global vaccination. Production of the vaccines usually requires years of research and testing before they can be used. In 2020, the scientific comm
Externí odkaz:
https://doaj.org/article/c8033b448e9f4731aeec45470974b414
Autor:
Diebold, Matthias, Locher, Eleonore, Boide, Philipp, Enzler-Tschudy, Annette, Faivre, Anna, Fischer, Ingeborg, Helmchen, Birgit, Hopfer, Helmut, Kim, Min Jeong, Moll, Solange, Nanchen, Giliane, Rotman, Samuel, Saganas, Charalampos, Seeger, Harald, Kistler, Andreas D
Publikováno v:
Kidney international, vol. 102, no. 6, pp. 1409-1419
Numerous cases of glomerulonephritis manifesting shortly after SARS-CoV-2 vaccination have been reported, but causality remains unproven. Here, we studied the association between mRNA-based SARS-CoV-2 vaccination and new-onset glomerulonephritis usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e4aecf781f9d083f107bd43fc22bbf7
https://doi.org/10.1016/j.kint.2022.08.021
https://doi.org/10.1016/j.kint.2022.08.021
Autor:
Ruby SM Tsang, Mark Joy, Rachel Byford, Chris Robertson, Sneha N Anand, William Hinton, Nikhil Mayor, Debasish Kar, John Williams, William Victor, Ashley Akbari, Declan T Bradley, Siobhan Murphy, Dermot O’Reilly, Rhiannon K Owen, Antony Chuter, Jillian Beggs, Gary Howsam, Aziz Sheikh, FD Richard Hobbs, Simon de Lusignan
Publikováno v:
Tsang, R SM, Joy, M, Byford, R, Robertson, C, Anand, S N, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, D T, Murphy, S, O’Reilly, D, Owen, R K, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FD R & Lusignan, S D 2023, ' Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021 : a national vaccine surveillance platform self-controlled case series study ', Eurosurveillance, vol. 28, no. 3 . https://doi.org/10.2807/1560-7917.ES.2023.28.3.2200195
Tsang, R SM, Joy, M, Byford, R, Robertson, C, Anand, S N, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, D T, Murphy, S, O'Reilly, D, Owen, R K, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FD R & de Lusignan, S 2023, ' Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021 : a national vaccine surveillance platform self-controlled case series study ', Eurosurveillance, vol. 28, no. 3 . https://doi.org/10.2807/1560-7917.ES.2023.28.3.2200195
Tsang, R S, Joy, M, Byford, R, Robertson, C, Anand, S N, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, D T, Murphy, S, O'Reilly, D, Owen, R K, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FD R & de Lusignan, S 2023, ' Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study ', EUROSURVEILLANCE, vol. 28, no. 3, 2200195 . https://doi.org/10.2807/1560-7917.ES.2023.28.3.2200195
Tsang, R SM, Joy, M, Byford, R, Robertson, C, Anand, S N, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, D T, Murphy, S, O'Reilly, D, Owen, R K, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FD R & de Lusignan, S 2023, ' Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021 : a national vaccine surveillance platform self-controlled case series study ', Eurosurveillance, vol. 28, no. 3 . https://doi.org/10.2807/1560-7917.ES.2023.28.3.2200195
Tsang, R S, Joy, M, Byford, R, Robertson, C, Anand, S N, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, D T, Murphy, S, O'Reilly, D, Owen, R K, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FD R & de Lusignan, S 2023, ' Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study ', EUROSURVEILLANCE, vol. 28, no. 3, 2200195 . https://doi.org/10.2807/1560-7917.ES.2023.28.3.2200195
Background Post-authorisation vaccine safety surveillance is well established for reporting common adverse events of interest (AEIs) following influenza vaccines, but not for COVID-19 vaccines. Aim To estimate the incidence of AEIs presenting to prim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::605363ab9da8612afeb7c2fa34e6153e
https://research-information.bris.ac.uk/ws/files/367996381/eurosurv_28_3_4.pdf
https://research-information.bris.ac.uk/ws/files/367996381/eurosurv_28_3_4.pdf
Publikováno v:
Shi, T, Robertson, C & Sheikh, A 2023, ' Effectiveness and safety of coronavirus disease 2019 vaccines ', Current opinion in pulmonary medicine, vol. 29, no. 3, pp. 138-142 . https://doi.org/10.1097/MCP.0000000000000948
PURPOSE OF REVIEW: To review and summarise recent evidence on the effectiveness of coronavirus disease 2019 (COVID-19) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 hospitalisation and death in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfba681d96c275c1ada7bde156e6c65
https://www.pure.ed.ac.uk/ws/files/329807621/Effectiveness_of_mRNA_boosters_after_homologous_primary_series_with_BNT162b2_or_ChAdOx1_against_symptomatic_infection_and_severe_COVID_19_in_Brazil_and_Scotland_A_test_negative_design_case_control_study_journal.pmed.1004156.pdf
https://www.pure.ed.ac.uk/ws/files/329807621/Effectiveness_of_mRNA_boosters_after_homologous_primary_series_with_BNT162b2_or_ChAdOx1_against_symptomatic_infection_and_severe_COVID_19_in_Brazil_and_Scotland_A_test_negative_design_case_control_study_journal.pmed.1004156.pdf
Autor:
Florian Stehlin, Francesco Tommasini, Véronique Monzambani-Banderet, Cedric Girard, Daniel Yerly, Camillo Ribi, Yannick D. Muller
Publikováno v:
Allergology international, vol. 72, no. 2, pp. 332-334
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b9d3bf0d9e35a55cf49d2bc8b0f52ad
https://serval.unil.ch/resource/serval:BIB_F1AE52F9BF9D.P002/REF.pdf
https://serval.unil.ch/resource/serval:BIB_F1AE52F9BF9D.P002/REF.pdf
Autor:
Pierre Ekobena, Laura E. Rothuizen, Francesca Bedussi, Pierre Guilcher, Sylvain Meylan, Alessandro Ceschi, François Girardin, Kim Dao
Publikováno v:
International journal of audiology, vol. 62, no. 6, pp. 587-591
To gain medical insight into the clinical course and safety of otolaryngologic disorders following immunisation with severe acute respiratory coronavirus (SARS-CoV-2) mRNA-based vaccines. Case description. We report four cases of transient audio-vest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb3082ffe33f65a073bcdcd0122f224a
https://doi.org/10.1080/14992027.2022.2056721
https://doi.org/10.1080/14992027.2022.2056721
Autor:
Fatemeh Torabi, Stuart Bedston, Emily Lowthian, Ashley Akbari, Rhiannon K. Owen, Declan T. Bradley, Utkarsh Agrawal, Peter Collins, Richard Fry, Lucy J. Griffiths, Jillian Beggs, Gareth Davies, Joe Hollinghurst, Jane Lyons, Hoda Abbasizanjani, Simon Cottrell, Malorie Perry, Richard Roberts, Amaya Azcoaga-Lorenzo, Adeniyi Francis Fagbamigbe, Ting Shi, Ruby S. M. Tsang, Chris Robertson, F. D. Richard Hobbs, Simon de Lusignan, Colin McCowan, Michael Gravenor, Colin R. Simpson, Aziz Sheikh, Ronan A. Lyons
Publikováno v:
Torabi, F, Bedston, S, Lowthian, E, Akbari, A, Owen, R K, Bradley, D T, Agrawal, U, Collins, P, Fry, R, Griffiths, L J, Beggs, J, Davies, G, Hollinghurst, J, Lyons, J, Abbasizanjani, H, Cottrell, S, Perry, M, Roberts, R, Azcoaga-Lorenzo, A, Fagbamigbe, A F, Shi, T, Tsang, R S M, Robertson, C, Hobbs, F D R, de Lusignan, S, McCowan, C, Gravenor, M, Simpson, C R, Sheikh, A & Lyons, R A 2022, ' Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test : a self-controlled case series analysis in Wales ', Scientific Reports, vol. 12, no. 1, 16406, pp. 16406 . https://doi.org/10.1038/s41598-022-20118-6
Torabi, F, Bedston, S, Lowthian, E, Akbari, A, Owen, R K, Bradley, D T, Agrawal, U, Collins, P, Fry, R, Griffiths, L J, Beggs, J, Davies, G, Hollinghurst, J, Lyons, J, Abbasizanjani, H, Cottrell, S, Perry, M, Roberts, R, Azcoaga-Lorenzo, A, Fagbamigbe, A F, Shi, T, Tsang, R S M, Robertson, C, Hobbs, F D R, de Lusignan, S, McCowan, C, Gravenor, M, Simpson, C R, Sheikh, A & Lyons, R A 2022, ' Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales ', Scientific Reports, vol. 12, 16406 . https://doi.org/10.1038/s41598-022-20118-6
Scientific Reports
Torabi, F, Bedston, S, Lowthian, E, Akbari, A, Owen, R K, Bradley, D T, Agrawal, U, Collins, P, Fry, R, Griffiths, L J, Beggs, J, Davies, G, Hollinghurst, J, Lyons, J, Abbasizanjani, H, Cottrell, S, Perry, M, Roberts, R, Azcoaga-Lorenzo, A, Fagbamigbe, A F, Shi, T, Tsang, R S M, Robertson, C, Hobbs, F D R, de Lusignan, S, McCowan, C, Gravenor, M, Simpson, C R, Sheikh, A & Lyons, R A 2022, ' Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales ', Scientific Reports, vol. 12, 16406 . https://doi.org/10.1038/s41598-022-20118-6
Scientific Reports
Funding: This work was supported by the Medical Research Council [MR/V028367/1]; Health Data Research UK [HDR-9006] which receives its funding from the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Soci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3574f1dc602d251565e4a136b14733fe
https://www.pure.ed.ac.uk/ws/files/300381484/Risk_of_thrombocytopenic_haemorrhagic_and_thromboembolic_disorders_following_COVID_19_vaccination_and_positive_test.pdf
https://www.pure.ed.ac.uk/ws/files/300381484/Risk_of_thrombocytopenic_haemorrhagic_and_thromboembolic_disorders_following_COVID_19_vaccination_and_positive_test.pdf
Publikováno v:
Arquivos Brasileiros de Oftalmologia, Issue: ahead, Published: 31 MAR 2023
A 51-year-old non-obese woman presented with a one-week history of progressive blurry vision within the inferior visual field of her left eye. Her only relevant past medical history was long-standing hypothyroidism and recent vaccination against Coro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______608::2c79c240f29b4764886884d71785335e
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492023005004301&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492023005004301&lng=en&tlng=en
Publikováno v:
Mills, N L, Patone, M & Hippisley-Cox, J 2023, ' Response by Mills et al Regarding Article, "Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex" ', Circulation, vol. 147, no. 10, pp. e655-e656 . https://doi.org/10.1161/CIRCULATIONAHA.122.063394
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e025c800be8c49fbe008ecd60e7e6b2d
https://doi.org/10.1161/circulationaha.122.063394
https://doi.org/10.1161/circulationaha.122.063394